Flow and tDCS Evidence Flow Overview Flow Webinars In-clinic Resources Marketing Materials

Flow and tDCS Evidence Flow Overview Flow Webinars In-clinic Resources Marketing Materials

Flow & tDCS Evidence

Data Pack front cover

Flow Neuroscience

May, 2024

Summary of Flow evidence including safety, efficacy, and side effect information

NHS Perinatal Publication 2024 June

Baukaite, E., Noel-Johnson, A., Walker, K., Griffiths, C.

Jun, 2024

Experiences and Value of Flow; Used at Home for Specialist Perinatal Mental Health Service and Maternal Loss Psychology Service Patients with Depression

NHS quant article may 2024

Griffiths, C., Maravic da Silva, K., Jiang, H., Smart, D., and Zafar, A.

May, 2024

Flow for Depression Treatment in a Primary Healthcare General Practice—Depression, Functioning, and Health-Related Quality of Life Outcomes

NHS Journal of Depression CMHT

Griffiths, C. , Walker, K. , Willis, A.

Feb, 2024

Qualitative Study Exploring the Experience and Value of Flow - Community Mental Health

NHS Journal of Depression GP

Griffiths, C. , Walker, K. , Jiang, H. , Noel-Johnson, A. and Zafar, A.

Nov, 2023

Qualitative Study Exploring the Experience and Value of Flow - Primary Care

Additional studies showcasing Flow

Flow RCT

Home-based tDCS is a potential first line treatment for MDD that is acceptable and safe

Ganho Ávila1 et al. 2022

Using Flow home-based tDCS in clinical practice; case series

Woodham et al. 2022

Is Flow a potential first line of treatment for depression?

Additional studies reviewing tDCS

tDCS antidepressant effects peak at 6 weeks

tDCS antidepressant effects peak at around 6 weeks

Frengi et al. 2021

tDCS for depression is definitely effective (level A evidence)

Moffa et al. 2020

A meta-analysis: tDCS was an effective intervention in reducing depressive symptoms